Table 2.
Groups | Vol-T (mL) | Vol-E (mL) | Vol-E/Vol-T | nFA-T | nADC-T | nFA-E | nADC-E | nCBF-T | nCBV-T | nCBF-E | nCBV-E |
---|---|---|---|---|---|---|---|---|---|---|---|
HGG | |||||||||||
N | 18 | 17 | 17 | 16 | 16 | 16 | 16 | 15 | 15 | 14 | 14 |
Median | 40.25 | 26.58 | 0.83 | 0.40 | 1.52 | 0.47 | 1.49 | 7.91 | 6.65 | 0.59 | 0.68 |
Range | 93.40 | 155.79 | 9.40 | 0.41 | 0.93 | 0.33 | 1.49 | 9.63 | 5.75 | 0.93 | 1.01 |
Minimum | 1.57 | 0.46 | 0.01 | 0.15 | 1.16 | 0.23 | 1.13 | 2.55 | 2.70 | 0.40 | 0.34 |
Maximum | 94.96 | 156.25 | 9.41 | 0.56 | 2.09 | 0.56 | 2.63 | 12.18 | 8.45 | 1.33 | 1.35 |
LGG | |||||||||||
N | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 | 10 |
Median | 22.46 | 10.15 | 0.37 | 0.25 | 1.86 | 0.44 | 1.46 | 2.80 | 3.33 | 1.08 | 0.94 |
Range | 59.50 | 38.07 | 0.85 | 0.16 | 0.85 | 0.24 | 0.56 | 2.33 | 4.97 | 1.34 | 1.19 |
Minimum | 7.64 | 3.06 | 0.16 | 0.19 | 1.67 | 0.32 | 1.39 | 1.47 | 1.26 | 0.52 | 0.54 |
Maximum | 67.14 | 41.13 | 1.01 | 0.35 | 2.52 | 0.56 | 1.96 | 3.79 | 6.22 | 1.86 | 1.74 |
MET | |||||||||||
N | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 | 15 |
Median | 14.61 | 50.28 | 2.88 | 0.31 | 1.54 | 0.41 | 1.85 | 7.70 | 6.91 | 0.73 | 0.86 |
Range | 66.04 | 109.39 | 6.51 | 0.31 | 1.14 | 0.24 | 1.29 | 8.17 | 9.29 | 1.12 | 1.95 |
Minimum | 5.54 | 2.20 | 0.33 | 0.18 | 1.14 | 0.27 | 1.39 | 2.49 | 3.55 | 0.41 | 0.31 |
Maximum | 71.57 | 111.58 | 6.84 | 0.49 | 2.28 | 0.51 | 2.68 | 10.67 | 12.84 | 1.53 | 2.25 |
Total | |||||||||||
N | 43 | 42 | 42 | 41 | 41 | 41 | 41 | 40 | 40 | 39 | 39 |
Median | 16.36 | 26.39 | 0.91 | 0.31 | 1.60 | 0.43 | 1.60 | 6.67 | 6.25 | 0.83 | 0.78 |
Range | 93.40 | 155.79 | 9.40 | 0.41 | 1.38 | 0.33 | 1.55 | 10.71 | 11.58 | 1.47 | 1.95 |
Minimum | 1.57 | 0.46 | 0.01 | 0.15 | 1.14 | 0.23 | 1.13 | 1.47 | 1.26 | 0.40 | 0.31 |
Maximum | 94.96 | 156.25 | 9.41 | 0.56 | 2.52 | 0.56 | 2.68 | 12.18 | 12.84 | 1.86 | 2.25 |
Abbreviations: HGG, high-grade gliomas; LGG, low-grade gliomas; MET, metastases; nFA-T, normalized fractional anisotropy-tumor; nADC-T, normalized-ADC-tumor; nFA-E, normalized fractional anisotropy-edema; nADC-E, normalized-ADC-edema; nCBF-T, normalized cerebral blood flow-tumor; nCBV-T, normalized cerebral blood volume-tumor; nCBF-E, nCBF-edema; nCBV-E, nCBV-edema.